Canavan Disease Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 79 pages | ID: C23CB98EFD3DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Canavan Disease Therapeutics in global, including the following market information:

Global Canavan Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Canavan Disease Therapeutics Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Canavan Disease Therapeutics companies in 2021 (%)

The global Canavan Disease Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gene Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Canavan Disease Therapeutics include Pfizer Inc and Turing Pharmaceuticals AG etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Canavan Disease Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Canavan Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Canavan Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Gene Therapy
• Recombinant Enzyme
• TUR-007
• Others

Global Canavan Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Canavan Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global Canavan Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Canavan Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Canavan Disease Therapeutics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Canavan Disease Therapeutics revenues share in global market, 2021 (%)

Key companies Canavan Disease Therapeutics sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Canavan Disease Therapeutics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc
• Turing Pharmaceuticals AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Canavan Disease Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Canavan Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANAVAN DISEASE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Canavan Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Canavan Disease Therapeutics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Canavan Disease Therapeutics Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Canavan Disease Therapeutics Players in Global Market
3.2 Top Global Canavan Disease Therapeutics Companies Ranked by Revenue
3.3 Global Canavan Disease Therapeutics Revenue by Companies
3.4 Global Canavan Disease Therapeutics Sales by Companies
3.5 Global Canavan Disease Therapeutics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Canavan Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Canavan Disease Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Canavan Disease Therapeutics Players in Global Market
  3.8.1 List of Global Tier 1 Canavan Disease Therapeutics Companies
  3.8.2 List of Global Tier 2 and Tier 3 Canavan Disease Therapeutics Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Canavan Disease Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Gene Therapy
  4.1.3 Recombinant Enzyme
  4.1.4 TUR-007
  4.1.5 Others
4.2 By Type - Global Canavan Disease Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Canavan Disease Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Canavan Disease Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Canavan Disease Therapeutics Revenue Market Share, 2017-2028
4.3 By Type - Global Canavan Disease Therapeutics Sales & Forecasts
  4.3.1 By Type - Global Canavan Disease Therapeutics Sales, 2017-2022
  4.3.2 By Type - Global Canavan Disease Therapeutics Sales, 2023-2028
  4.3.3 By Type - Global Canavan Disease Therapeutics Sales Market Share, 2017-2028
4.4 By Type - Global Canavan Disease Therapeutics Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Canavan Disease Therapeutics Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Canavan Disease Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Canavan Disease Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Canavan Disease Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Canavan Disease Therapeutics Revenue Market Share, 2017-2028
5.3 By Application - Global Canavan Disease Therapeutics Sales & Forecasts
  5.3.1 By Application - Global Canavan Disease Therapeutics Sales, 2017-2022
  5.3.2 By Application - Global Canavan Disease Therapeutics Sales, 2023-2028
  5.3.3 By Application - Global Canavan Disease Therapeutics Sales Market Share, 2017-2028
5.4 By Application - Global Canavan Disease Therapeutics Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Canavan Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Canavan Disease Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Canavan Disease Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Canavan Disease Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Canavan Disease Therapeutics Revenue Market Share, 2017-2028
6.3 By Region - Global Canavan Disease Therapeutics Sales & Forecasts
  6.3.1 By Region - Global Canavan Disease Therapeutics Sales, 2017-2022
  6.3.2 By Region - Global Canavan Disease Therapeutics Sales, 2023-2028
  6.3.3 By Region - Global Canavan Disease Therapeutics Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Canavan Disease Therapeutics Revenue, 2017-2028
  6.4.2 By Country - North America Canavan Disease Therapeutics Sales, 2017-2028
  6.4.3 US Canavan Disease Therapeutics Market Size, 2017-2028
  6.4.4 Canada Canavan Disease Therapeutics Market Size, 2017-2028
  6.4.5 Mexico Canavan Disease Therapeutics Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Canavan Disease Therapeutics Revenue, 2017-2028
  6.5.2 By Country - Europe Canavan Disease Therapeutics Sales, 2017-2028
  6.5.3 Germany Canavan Disease Therapeutics Market Size, 2017-2028
  6.5.4 France Canavan Disease Therapeutics Market Size, 2017-2028
  6.5.5 U.K. Canavan Disease Therapeutics Market Size, 2017-2028
  6.5.6 Italy Canavan Disease Therapeutics Market Size, 2017-2028
  6.5.7 Russia Canavan Disease Therapeutics Market Size, 2017-2028
  6.5.8 Nordic Countries Canavan Disease Therapeutics Market Size, 2017-2028
  6.5.9 Benelux Canavan Disease Therapeutics Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Canavan Disease Therapeutics Revenue, 2017-2028
  6.6.2 By Region - Asia Canavan Disease Therapeutics Sales, 2017-2028
  6.6.3 China Canavan Disease Therapeutics Market Size, 2017-2028
  6.6.4 Japan Canavan Disease Therapeutics Market Size, 2017-2028
  6.6.5 South Korea Canavan Disease Therapeutics Market Size, 2017-2028
  6.6.6 Southeast Asia Canavan Disease Therapeutics Market Size, 2017-2028
  6.6.7 India Canavan Disease Therapeutics Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Canavan Disease Therapeutics Revenue, 2017-2028
  6.7.2 By Country - South America Canavan Disease Therapeutics Sales, 2017-2028
  6.7.3 Brazil Canavan Disease Therapeutics Market Size, 2017-2028
  6.7.4 Argentina Canavan Disease Therapeutics Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Canavan Disease Therapeutics Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Canavan Disease Therapeutics Sales, 2017-2028
  6.8.3 Turkey Canavan Disease Therapeutics Market Size, 2017-2028
  6.8.4 Israel Canavan Disease Therapeutics Market Size, 2017-2028
  6.8.5 Saudi Arabia Canavan Disease Therapeutics Market Size, 2017-2028
  6.8.6 UAE Canavan Disease Therapeutics Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pfizer Inc
  7.1.1 Pfizer Inc Corporate Summary
  7.1.2 Pfizer Inc Business Overview
  7.1.3 Pfizer Inc Canavan Disease Therapeutics Major Product Offerings
  7.1.4 Pfizer Inc Canavan Disease Therapeutics Sales and Revenue in Global (2017-2022)
  7.1.5 Pfizer Inc Key News
7.2 Turing Pharmaceuticals AG
  7.2.1 Turing Pharmaceuticals AG Corporate Summary
  7.2.2 Turing Pharmaceuticals AG Business Overview
  7.2.3 Turing Pharmaceuticals AG Canavan Disease Therapeutics Major Product Offerings
  7.2.4 Turing Pharmaceuticals AG Canavan Disease Therapeutics Sales and Revenue in Global (2017-2022)
  7.2.5 Turing Pharmaceuticals AG Key News

8 GLOBAL CANAVAN DISEASE THERAPEUTICS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Canavan Disease Therapeutics Production Capacity, 2017-2028
8.2 Canavan Disease Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Canavan Disease Therapeutics Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 CANAVAN DISEASE THERAPEUTICS SUPPLY CHAIN ANALYSIS

10.1 Canavan Disease Therapeutics Industry Value Chain
10.2 Canavan Disease Therapeutics Upstream Market
10.3 Canavan Disease Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Canavan Disease Therapeutics Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Canavan Disease Therapeutics in Global Market
Table 2. Top Canavan Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Canavan Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Canavan Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 5. Global Canavan Disease Therapeutics Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Canavan Disease Therapeutics Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Canavan Disease Therapeutics Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Canavan Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Canavan Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Canavan Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Canavan Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Canavan Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Canavan Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Canavan Disease Therapeutics Sales (K Pcs), 2017-2022
Table 15. By Type - Global Canavan Disease Therapeutics Sales (K Pcs), 2023-2028
Table 16. By Application – Global Canavan Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Canavan Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Canavan Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Canavan Disease Therapeutics Sales (K Pcs), 2017-2022
Table 20. By Application - Global Canavan Disease Therapeutics Sales (K Pcs), 2023-2028
Table 21. By Region – Global Canavan Disease Therapeutics Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Canavan Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Canavan Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Canavan Disease Therapeutics Sales (K Pcs), 2017-2022
Table 25. By Region - Global Canavan Disease Therapeutics Sales (K Pcs), 2023-2028
Table 26. By Country - North America Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Canavan Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Canavan Disease Therapeutics Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Canavan Disease Therapeutics Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Canavan Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Canavan Disease Therapeutics Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Canavan Disease Therapeutics Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Canavan Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Canavan Disease Therapeutics Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Canavan Disease Therapeutics Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Canavan Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Canavan Disease Therapeutics Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Canavan Disease Therapeutics Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Canavan Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Canavan Disease Therapeutics Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Canavan Disease Therapeutics Sales, (K Pcs), 2023-2028
Table 46. Pfizer Inc Corporate Summary
Table 47. Pfizer Inc Canavan Disease Therapeutics Product Offerings
Table 48. Pfizer Inc Canavan Disease Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Turing Pharmaceuticals AG Corporate Summary
Table 50. Turing Pharmaceuticals AG Canavan Disease Therapeutics Product Offerings
Table 51. Turing Pharmaceuticals AG Canavan Disease Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Canavan Disease Therapeutics Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 53. Global Canavan Disease Therapeutics Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Canavan Disease Therapeutics Production by Region, 2017-2022 (K Pcs)
Table 55. Global Canavan Disease Therapeutics Production by Region, 2023-2028 (K Pcs)
Table 56. Canavan Disease Therapeutics Market Opportunities & Trends in Global Market
Table 57. Canavan Disease Therapeutics Market Drivers in Global Market
Table 58. Canavan Disease Therapeutics Market Restraints in Global Market
Table 59. Canavan Disease Therapeutics Raw Materials
Table 60. Canavan Disease Therapeutics Raw Materials Suppliers in Global Market
Table 61. Typical Canavan Disease Therapeutics Downstream
Table 62. Canavan Disease Therapeutics Downstream Clients in Global Market
Table 63. Canavan Disease Therapeutics Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Canavan Disease Therapeutics Segment by Type
Figure 2. Canavan Disease Therapeutics Segment by Application
Figure 3. Global Canavan Disease Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Canavan Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Canavan Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. Canavan Disease Therapeutics Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Canavan Disease Therapeutics Revenue in 2021
Figure 9. By Type - Global Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 10. By Type - Global Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Type - Global Canavan Disease Therapeutics Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 13. By Application - Global Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 14. By Application - Global Canavan Disease Therapeutics Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 16. By Region - Global Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 17. By Country - North America Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 18. By Country - North America Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 19. US Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 24. Germany Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. France Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 33. China Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. India Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 39. By Country - South America Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 40. Brazil Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Canavan Disease Therapeutics Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Canavan Disease Therapeutics Sales Market Share, 2017-2028
Figure 44. Turkey Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Canavan Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 48. Global Canavan Disease Therapeutics Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Canavan Disease Therapeutics by Region, 2021 VS 2028
Figure 50. Canavan Disease Therapeutics Industry Value Chain
Figure 51. Marketing Channels